Sign in

GenTraceDx

@gentrace.com
5 followers 4 following 1 posts

GenTraceDx is the first living cancer diagnostic, continuously updating to identify new treatment options and clinical trials, and notifying patients and physicians in real time. Backed by Genome Canada and Genome BC. gentrace.com

PostsRepliesMedia
GenTraceDx @gentrace.com · 26/06/2026
Traditional cancer genomic testing produces a one-time report. As new therapies are approved, trials open, and biomarkers are identified, the report does not update. GenTraceDx secured ~$6M in GAPP funding to change this: buff.ly/1d2nzu8 @bcgsc.ca @genomecanada.ca @genomebc.bsky.social #Genomics
buff.ly
Canadian Team Advances Breakthrough "Living" Cancer Diagnostic Platform Following National GAPP Funding
/CNW/ - Genetrack Biolabs, working in partnership with Canada's Michael Smith Genome Sciences Centre as part of a landmark research–industry collaboration, has...
011